Colouring matters for medicinal products (recast)

This procedure updates the regulations regarding the use of coloring substances in medicines. It aims to ensure that dyes used in pharmaceuticals are safe for patients and that their use is justified, such as for identifying different strengths of the same medication or improving stability.

This will affect pharmaceutical manufacturers and healthcare providers. It ensures a harmonized safety standard across the EU for the additives used in the production of medicines.